These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 2511610)

  • 1. Long term haemodynamic, pulmonary function and symptomatic effects of pirbuterol in COPD.
    Neilly JB; Carter R; Tweddel A; Martin W; Hutton I; Banham SW; Stevenson RD
    Respir Med; 1989 Jan; 83(1):59-65. PubMed ID: 2511610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of pirbuterol and sodium nitroprusside on pulmonary haemodynamics in hypoxic cor pulmonale.
    MacNee W; Wathen CG; Hannan WJ; Flenley DC; Muir AL
    Br Med J (Clin Res Ed); 1983 Oct; 287(6400):1169-72. PubMed ID: 6138118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pirbuterol. A preliminary review of its pharmacological properties and therapeutic efficacy in reversible bronchospastic disease.
    Richards DM; Brogden RN
    Drugs; 1985 Jul; 30(1):6-21. PubMed ID: 2863125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of pirbuterol acetate, metaproterenol, and placebo aerosols on pulmonary function and incidence of cardiac ectopy.
    Chodosh S; Crooks LA; Tuck J
    J Asthma; 1989; 26(5):309-15. PubMed ID: 2484663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of six months of daily treatment with the beta-2 agonist oral pirbuterol on pulmonary hemodynamics in patients with chronic hypoxic cor pulmonale receiving long-term oxygen therapy.
    Biernacki W; Prince K; Whyte K; MacNee W; Flenley DC
    Am Rev Respir Dis; 1989 Feb; 139(2):492-7. PubMed ID: 2563321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonbronchodilator effects of pirbuterol and ipratropium in chronic obstructive pulmonary disease.
    Ashutosh K; Dev G; Steele D
    Chest; 1995 Jan; 107(1):173-8. PubMed ID: 7813271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pirbuterol hydrochloride: evaluation of beta adrenergic agonist activity in reversible obstructive pulmonary disease and congestive heart failure.
    Weber RW; Nelson HS
    Pharmacotherapy; 1984; 4(1):1-10. PubMed ID: 6142449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of urapidil therapy on hemodynamics and gas exchange in exercising patients with chronic obstructive pulmonary disease and pulmonary hypertension.
    Adnot S; Andrivet P; Piquet J; Brun-Buisson C; Rauss A; Bignon J; Lemaire F
    Am Rev Respir Dis; 1988 May; 137(5):1068-74. PubMed ID: 3143277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group.
    Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ
    Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term effects of inhalative tiotropium/formoterol/budenoside versus tiotropium/formoterol in patients with newly diagnosed chronic obstructive pulmonary disease requiring surgery for lung cancer: a prospective randomized trial.
    Bölükbas S; Eberlein M; Eckhoff J; Schirren J
    Eur J Cardiothorac Surg; 2011 Jun; 39(6):995-1000. PubMed ID: 20970351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute bronchial and cardiovascular effects of oral pirbuterol and metaproterenol.
    Ence TJ; Tashkin DP; Ho D; Child JS
    Ann Allergy; 1979 Oct; 43(4):229-36. PubMed ID: 555600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The acute hemodynamic response to pirbuterol at rest and exercise in patients with heart failure with observations on long-term response.
    Uretsky BF; Seecof RM; Reddy PS
    Can J Cardiol; 1986; 2(2):80-5. PubMed ID: 3085906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term oral bronchodilator therapy of asthma with pirbuterol.
    Burki NK; Diamond L
    Clin Pharmacol Ther; 1978 Jul; 24(1):84-9. PubMed ID: 657723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of Sch 1000 (Atrovent) on pulmonary haemodynamics, ventilation, and pulmonary gas exchange in patients with chronic obstructive disease of the lungs (author's transl)].
    Hawrylkiewicz I; Gluskowski J; Zielinski J
    Bratisl Lek Listy; 1979 Mar; 71(3):303-8. PubMed ID: 445180
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease.
    Belman MJ; Botnick WC; Shin JW
    Am J Respir Crit Care Med; 1996 Mar; 153(3):967-75. PubMed ID: 8630581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repetitive hemodilution in chronic obstructive pulmonary disease and pulmonary hypertension: effects on pulmonary hemodynamics, gas exchange, and exercise capacity.
    Borst MM; Leschke M; König U; Worth H
    Respiration; 1999; 66(3):225-32. PubMed ID: 10364738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose almitrine bismesylate in the treatment of hypoxemia due to chronic obstructive pulmonary disease.
    Winkelmann BR; Kullmer TH; Kneissl DG; Trenk D; Kronenberger H
    Chest; 1994 May; 105(5):1383-91. PubMed ID: 8181324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addition of anticholinergic solution prolongs bronchodilator effect of beta 2 agonists in patients with chronic obstructive pulmonary disease.
    Levin DC; Little KS; Laughlin KR; Galbraith JM; Gustman PM; Murphy D; Kram JA; Hardie G; Reuter C; Ostransky D; McFarland K; Petty TL; Silvers W; Rennard SI; Mueller M; Repsher LH; Zuwallack RL; Vale R
    Am J Med; 1996 Jan; 100(1A):40S-48S. PubMed ID: 8610716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticholinergic versus beta 2-agonist on gas exchange in COPD: a comparative study in 15 patients.
    Pillet O; Manier G; Castaing Y
    Monaldi Arch Chest Dis; 1998 Feb; 53(1):3-8. PubMed ID: 9632900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of pirbuterol and pirbuterol and hydroxyzine in patients with reversible airway obstruction.
    Poppius H; Lehti H; Stenius-Aarniala B
    Eur J Clin Pharmacol; 1979 Jul; 15(6):389-93. PubMed ID: 387417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.